APA

de Luis D. A., Sagrado M. G., Pacheco D., Terroba M. C., Martin T., Cuellar L. & Ventosa M. (20110204). Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery. : Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Chicago

de Luis D A, Sagrado M Gonzalez, Pacheco D, Terroba M C, Martin T, Cuellar L and Ventosa M. 20110204. Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery. : Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Harvard

de Luis D. A., Sagrado M. G., Pacheco D., Terroba M. C., Martin T., Cuellar L. and Ventosa M. (20110204). Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery. : Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

MLA

de Luis D A, Sagrado M Gonzalez, Pacheco D, Terroba M C, Martin T, Cuellar L and Ventosa M. Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery. : Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 20110204.